News
Hikma launches generic version of Vyvanse® following FDA approval
News
Hikma launches Vancomycin Hydrochloride for Injection, USP, in the US
News
Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa
Watch a video message from our new CEO, Riad Mishlawi
#OwnYourCareer@Hikma
Meet Filipa Calisto, Associate Director, Portfolio & Commercial Operations, EU, and discover why she likes working at Hikma!
#OwnYourCareer@Hikma
Meet Kimberly Lembo, Associate Director, Contract Lifecycle Management and Systems, US and discover why she loves working at Hikma!
#OwnYourCareer@Hikma
Meet Alexander Liang, Trade Operations, US and discover why he loves working at Hikma!
Latest blogpost
Read the latest blog post by Lana Ghanem, Managing Director, Hikma Ventures and Vice President, Digital Health Investments & Partnerships - Investing in the disruptive future of the pharmaceutical industry.
Careers
Join us in helping to put better health within reach for millions of people
Find out more
Our 2022 Sustainability Report
Find out more
Our 2022 Annual Report